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The cytoplasmic loops of rhodopsin, the rod cell pho-
toreceptor, play important regulatory roles in the acti-
vation of both rhodopsin kinase and the rod cell G pro-
tein, Gt. A number of studies have identified domains in 
rhodopsin that are important for the activation of Gt. 
However, less is known concerning the cytoplasmic re-
gions that regulate phosphorylation of the photorecep-
tor by rhodopsin kinase. To identify regions that partic-
ipate in these processes, a series of alanine mutations 
were generated in the three cytoplasmic loops of rho-
dopsin and transiently expressed in HEK-293 cells. 
Membranes prepared from these cells were reconsti-
tuted with the opsin chromophore, 11-cis-retinal, and 
characterized for their ability to undergo light-depend-
ent phosphorylation by rhodopsin kinase and to cata-
lyze GTP,S (guanosine 5'-0-(3-thiotriphosphate)) bind-
ing to Gt. We have identified mutants that fall into three 
distinct categories: 1) those that show altered phospho-
rylation but normal Gt activation, such as T62A/V63A/ 
Q64A and Rl47AIF148A/Gl49A in Loops I and II, respec-
tively; 2) mutants that have reduced ability to activate 
Gt but are phosphorylated normally, including T242AI 
T243A and V250A!r251AIR252A in Loop m; and 3) mu-
tants that affect both phosphorylation and Gt activation, 
including A233G/A234G/A235G and A233N/A234N/A235N 
in Loop m. The use of these two assays in parallel have 
allowed us to distinguish the presence of distinct func-
tional domains within the cytoplasmic loops which are 
specific for interaction with rhodopsin kinase or Gt. 
G protein-coupled receptors are members of a large multi-
gene family having seven transmembrane-spanning domains 
that regulate intracellular signaling pathways in response to 
external stimuli (Fig. 1). Their function is the activation of 
heterotrimeric G proteins, which regulate a growing list of 
effector enzymes important in cell growth control and metabo-
lism. One mechanism to limit continuous G protein activation 
is homologous desensitization, which is mediated by phospho-
rylation of the receptors followed by the binding of a member of 
the arrestin family of proteins. These events result in the 
generation of receptors unable to interact with their G proteins. 
The phosphorylation is mediated by a class of serine/threonine 
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kinases, known as G protein-coupled receptor kinases (GRKs), 1 
which bind only the ligand-activated form of the receptors (1, 
2). Rhodopsin, the photoreceptor of the mammalian rod cell, 
has been used extensively as a model for defining the molecular 
interactions between receptors, their G proteins, and the GRKs 
that mediate desensitization. 
Studies of several different G protein-coupled receptors, in-
cluding rhodopsin, have suggested that the cytoplasmic loops 
(Fig. 1) play important roles in their interactions with G pro-
teins (3-11). In contrast, far less is known concerning the 
critical sites of interaction between these receptors and GRKs. 
A series of 7 serines and threonines on the C terminus of 
rhodopsin serve as phosphoacceptor sites for rhodopsin kinase, 
the rod cell GRK, although only one or two are thought to be 
physiologically relevant (4, 12, 13). Peptide competition studies 
have suggested that the cytoplasmic loops of the photoreceptor 
protein are involved in phosphorylation of rhodopsin by rho-
dopsin kinase (14, 15). In addition, the efficient phosphoryla-
tion of a synthetic peptide corresponding to the C terminus 
requires activation of the kinase by the cytoplasmic loops of 
rhodopsin (16-18). Mastoparan, which can activate several G 
proteins in place of their receptors, also potentiates the phos-
phorylation of the synthetic peptide substrate by rhodopsin 
kinase (18). These data suggest that the cytoplasmic loops of 
rhodopsin participate in the light-dependent activation of the 
kinase, allowing it to phosphorylate its substrate sites on the C 
terminus. 
Using a series of alanine mutations in the three cytoplasmic 
loops of rhodopsin, we have examined the phosphorylation of 
rhodopsin by rhodopsin kinase. To control for mutations that 
may cause extensive conformational changes in the cytoplas-
mic loops and therefore disrupt the ability of light to activate 
rhodopsin, we have also measured the activation of the rod cell 
G protein, Gt. We have identified mutants that fall into three 
distinct categories: 1) those that affect phosphorylation by rho-
dopsin kinase, 2) those that affect Gt activation, and 3) muta-
tions that affect both of these processes. The parallel use of 
these two assays has allowed us to begin to discriminate do-
mains on the cytoplasmic surface of rhodopsin that participate 
in the phosphorylation of rhodopsin by rhodopsin kinase from 
those that are involved in the activation of Gt. 
EXPERIMENTAL PROCEDURES 
Materials-All reagents for mutagenesis, including the Altered Sites 
mutagenesis kit, were obtained from Promega. The expression vector 
pcDNAI/Amp was purchased from Invitrogen. Bovine retinae were pur-
chased from J. A. Lawson Inc. (Lincoln, NB). Human embryonic kidney-
293 (HEK-293) cells were from American Type Culture Collection. The 
1 The abbreviations used are: GRK, G protein-coupled receptor ki-
nase; G,, transducin; HEK-293, human embryonic kidney-293; ROS, 
rod outer segment; GTP-yS, guanosine 5' -0-(3-thiotriphosphate); PAGE, 
polyacrylamide gel electrophoresis; CHAPS, 3-[(3-cholamidopropyl)-
dimethylammonio]propanesulfonic acid; TBS, Tris-buffered saline. 
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eDNA for bovine opsin and pRSV-TAg, a vector expressing T antigen, 
were gifts from Dr. Jeremy Nathans. The monoclonal antibody R2-15N 
was a gift from Dr. Paul Hargrave. The opsin chromophore, 11-cis-
retinal, was a gift from Roffman-La Roche. Radiolabeled nucleotides 
were purchased from Amersham Corp. or DuPont NEN. Oligonucleo-
tides were synthesized at a facility of the University of North Carolina 
Lineberger Comprehensive Cancer Center using an automated synthe-
sizer from Applied Biosystems. 
Cloning and Mutagenesis-The insertion of the eDNA for bovine 
opsin into pSelect and the methods for generating point mutants using 
the Altered Sites mutagenesis kit (Promega) have been described pre-
viously (19). All mutations were confirmed by dideoxy chain termina-
tion sequencing methods using Sequenase (U. S. Biochemical Corp.). 
The cDNAs for mutants showing differences in phosphorylation or G, 
activation were fully sequenced at the Automated DNA Sequencing 
Facility at the University of North Carolina at Chapel Hill on a model 
373A DNA Sequencer (Applied Biosystems) using the Taq DyeDeoxy®' 
terminator cycle sequencing kit (Applied Biosystems). 
Expression of Bouine Rhodopsin in HEK-293 Cells-The cDNAs for 
wild-type opsin and for the mutants were ligated into pcDNAI/Amp and 
cotransfected with pRSV-TAg into HEK-293 cells. All procedures for 
transfection and expression of bovine rhodopsin in HEK-293 cells using 
DEAE-dextran have been described previously (19). 
Preparation of Membranes-Membranes were prepared from trans-
fected cells approximately 65-70 h after transfection according to meth-
ods described previously (19). Protein concentrations were determined 
using procedures developed by Bradford (20). The expression of rhodop-
sin in HEK-293 cells was determined by Western analysis using the 
monoclonal antibody R2-15N, which recognizes theN terminus of the 
photoreceptor protein (21). Methods for electrophoresis and immuno-
blotting have been described previously (19). The levels of expression 
for wild-type and mutant rhodopsins were estimated using a Molecular 
Dynamics Phosphorlmager. Because the expressed rhodopsin migrates 
as multiple bands on polyacrylamide gels, the entire lane was measured 
for each sample. After subtraction of a background estimated from a 
lane of nontransfected cell membranes, the amount of rhodopsin was 
calculated using the concentration of rhodopsin in rod outer segment 
(ROS) membranes as a standard. The purification of ROS membranes 
has been described previously (22). 
Phosphorylation of Rhodopsin Mutants By Rhodopsin Kinase-
Light-exposed ROS, isolated from bovine retinae on sucrose gradients, 
were incubated in 200 mM NaHepes, 20 mM EDTA, 2 mM dithiothreitol, 
pH 8.0, and centrifuged for 30 min at 200,000 X g to extract rhodopsin 
kinase as described (14). To standardize the level of kinase activity in 
the phosphorylation reaction, each rhodopsin kinase preparation was 
used to phosphorylate 2 ILg of ROS membranes in the kinase assay 
buffer (described below) for 60 min and quantified by SDS-PAGE and 
phosphorimage analysis. For the expressed wild-type and mutant 
opsins, HEK-293 cell membranes containing 1 ,.,.g of rhodopsin were 
used in the phosphorylation assay. The amount of total protein in the 
reaction mixture was held constant at approximately 75-80 ,.,.g by 
supplementing the samples with membranes from nontransfected cells. 
The membranes were reconstituted with 28 iJ.M 11-cis-retinal (14 
nmol/80 ,.,.g of membrane protein) for 1 h at room temperature in the 
dark. After centrifugation at 12,000 X g for 15 min at room temperature 
to pellet membranes and remove unbound material, the membranes 
were resuspended in 10 mM Tris-HCl, pH 7.4, 260 mM NaCl, 5 mM 
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FIG. 1. Amino acid sequence of the cytoplasmic domains of 
bovine rhodopsin. I, II, and III designate the three intracellular 
loops. N represents the fourth cytoplasmic loop formed by the palmi-
toylation of cysteines 322 and 323 and their attachment to the plasma 
membrane. K296 is the lysine that forms the attachment site for 11-
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FIG. 2. Time cou rse of phosphorylation of wild-type rhodopsin 
expressed in HEK-293 cells . A, autorad iogram of time course of 
pho phoryla tion . Membra nes reconstituted with 11-cis -retinal were 
phosphoryla ted in the light or in t he dark for the indicated times, as 
de cri bed under "Experimental Procedures," and chromatographed on a 
10% polyacr·ylamide gel, followed by autoradiography. B, quantification 
by phosphorimage analysis . The dried gel from A containing samples 
phosphorylated in the light (0 ) and in the dark (e ) was exposed to a 
Molecular Dynamics phosphorimage screen and subjected to phosphor-
image ana lysis using a Molecular Dynamics Phosphorlmager . 
aF , 1 IJ.M okadaic acid, and 150 IJ.M [32P]ATP (50 IJ.Cilml) in a r·eaction 
volume of 250 I-Ll. The reaction was ini tiated by the addition of the 
appropriate amount of rhodopsin kinase extract (approximately 60 ~J.D. 
The samples were incubated for 8 min at 30 •c under fluorescent room 
lights or in the da rk under Kodak No. 2 safelight filters. The reaction 
was terminated by incubation on ice for 2 min followed by the addition 
of500 I-Ll of ice-cold 10 mM ATP neutra lized with 0.1 M Tris-HCI, pH 7.5, 
and centr·ifugation for 15 min at 12,000 X g at room temperature . The 
pellets were ext racted for 1 h with 1.5% octylglucoside in 10 mM Tris-
HCI, pH 7.4, 150 mM NaCI, pH 7.4 (TBS), containing 50 mM NaF and 
cent rifuged for 15 min at 12,000 X g to remove insoluble materia l. The 
supernatants were incubated with the R2-15N monoclonal antibody fo r 
1 h at room temperature, fo llowed by incubation with Protein A-Sepha-
rose beads (30 I-Ll of a 50% slurTy in TBS containing 50 mM NaF) for 1 
h. The mixtures were centrifuged for 4 min at 50 X g to pellet the 
immune complexes. The immunoprecipi tates were washed three times 
in TBS containing 0.1'11 sodium deoxycholate and 50 mM NaF . The 
antigen/antibody complexes were released fmm the beads by incubation 
in SDS-Laemmli sample buffer (23) and analyzed by SDS-PAGE on 10% 
polyacrylamide ge ls. The radioactivity was quantified by phosphorim-
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FIG. 3. Phosphorylation and G, activation of Loop I mu tants. A, 
phosphoryla tion by rhodopsin kinase. Membranes from transfected 
HEK-293 cells were ha rvested, reconsti tuted with 11-cis-retinal, and 
assayed for phosphorylat ion in the light and in the da rk according to 
procedures described under· "Experimental Procedures." After subtract· 
ing the da rk values from the phosphorylation in the light, the results 
were expressed as a fraction of the level of light-dependent phosphoryl-
ation for wild-type rhodopsin n01·malized to a value of 1.0. The results 
represent the averages of duplicates from at least two transfections. 
The error bars represent S.E . B, t ime cour e of phosphorylation of 
T62AN63A/Q64A compared to wild-type rhodopsin. Membranes were 
phosphorylated and quantified as described under "Experimental Pro-
cedures" and in the legend to Fig. 2. Phoshorylation was performed in 
the light (open symbols) or in the da rk (closed symbols). 0 and • , 
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dark was subtracted from the amount in the light. The data were 
normalized to the level of light-dependent phosphorylation of wild-type 
rhodopsin expressed in HEK-293 cells. The absolute amount of phos-
phate incorporated per mole of rhodopsin was estimated from the im-
munoprecipitates by cutting out the lanes from the gel and quantifying 
the level of radioactivity by liquid scintillation spectrometry. 
Activation o{G,-Light-dependent activation ofG, was assayed using 
( 35S]GTP-y8 binding as described previously (19). The assay mixture 
contained 2.5 ILg of membrane protein and 0.5 ILM G, purified from ROS 
membranes. The reaction was initiated by the addition of 1 ILM 
[35S]GTP-yS (6.25 Cilnmol). At 30, 60, 90, 120, and 150 s, aliquots were 
removed from the reaction mixture, applied to nitrocellulose filter discs 
(Millipore) and washed with assay buffer to remove unbound GTP-yS. 
The level of GTP-yS binding to G, was quantified by liquid scintillation 
spectrometry. Under these conditions, the time courses were linear. 
Therefore, initial rates of activation could be determined from the 
slopes of the reaction curves fitted by linear regression analysis using 
the computer program Deltagraph Professional. The rates of activation 
were normalized to the levels of expression of the rhodopsin mutants 
quantified by Western analysis and normalized to the rate of activation 
in wild-type expressed rhodopsin. 
Retinal Binding-Membranes expressing wild-type or mutant rho-
dopsin were incubated in 11-cis-retinal in the dark as described above, 
then solubilized in 50 mM NaHepes, 140 mM NaCl, 3 mM MgCl2 , 2 mM 
EDTA, 1 mM DTT containing 2% CHAPS. Absorption spectra were 
measured in the dark and in the light and a subtraction spectra calcu-
lated as described previously (19). The extinction coefficient was as-
sumed to be the same for wild-type and mutant rhodopsins. Membranes 
solubilized in 1.5% octylglucoside gave identical results (data not 
shown). 
RESULTS 
Expression of Bovine Rhodopsin Mutants in HEK-293 Cells-
The cytoplasmic loops of rhodopsin were subjected primarily to 
alanine-scanning mutagenesis (Table I). Alanine was chosen 
because it is a neutral amino acid found at both exposed and 
buried positions that does not cause severe changes in second-
ary structure (24-26). These mutants were expressed in HEK-
293 cells, and membranes were prepared for phosphorylation 
and Gt activation experiments. Previously, truncation mutants 
expressed in these cells showed changes in glycosylation pat-
tern that appeared to result from altered transmembrane fold-
ing (19, 27). Western analysis showed no obvious difference in 
glycosylation pattern between the wild-type protein and the 
mutants, suggesting that the transmembrane folding of these 
proteins is not affected (data not shown). All of the mutants 
showing differences, compared to wild-type expressed rhodop-
sin, in phosphorylation by rhodopsin kinase or in the activation 
of Gt were also assayed for their ability to bind 11-cis-retinal. 
None of these mutants displayed altered retinal binding, also 
suggesting that the overall tertiary structure of these proteins 
was normal (data not shown). 
Phosphorylation of Bovine Rhodopsin Expressed in HEK-293 
Cells-A method for measuring the phosphorylation of rhodop-
sin expressed in HEK-293 cells was developed using an anti-
body directed against the N terminus of rhodopsin (21) to 
immunoprecipitate phosphorylated rhodopsin from the mem-
branes. A time course in the light, shown in Fig. 2, demon-
strates that the reaction reaches a plateau in approximately 60 
min, similar to results obtained by Bhattacharya et al. (28) 
wild-type rhodopsin; /';. and A, T62AN63A/Q64A. C, activation of G,. 
Membranes expressing mutant rhodopsins were reconstituted with 11-
cis-retinal and assayed for the light-dependent binding of GTP-yS to G, 
purified from rod outer segments as described under "Experimental 
Procedures." Rates of activation were calculated from the slopes of the 
reaction curves. After subtracting the rates of samples incubated in the 
dark, light-dependent GTP-yS binding was expressed as a fraction of 
wild-type rhodopsin normalized to a value of 1.0. The results represent 
the average of at least two independent transfections performed in 
duplicate. The error bars represent S.E. The average rate of GTP-yS 
binding for wild-type rhodopsin was 0.1 molls·mol. 
using COS-1 cell-expressed bovine rhodopsin and to results in 
our laboratory using ROS membranes (data not shown). In 
contrast, membranes incubated in the dark demonstrate no 
significant increase in phosphorylation even after 60 min. On 
the basis of this time course, membranes from cells expressing 
mutant rhodopsins were incubated for 8 min in the presence of 
rhodopsin kinase. This time represents a point in the curve 
that gives a detectable signal and is close to linearity. Approx-
imately 0.2 mol of phosphate/mol of rhodopsin is incorporated 
under these conditions. 
Mutations in Loop [-Cytoplasmic Loop I is a relatively 
short, highly basic loop that is well conserved between inver-
tebrate and vertebrate rhodopsin and between the mammalian 
cone and rod opsins (4). Table I shows the sequences of the 
mutations generated in this loop. Each amino acid was changed 
to alanine with the exception ofHis65, which was mutated to a 
tyrosine. Fig. 3A demonstrates that most of the mutants are 
similar to the wild-type protein in their ability to be phospho-
rylated by rhodopsin kinase except for T62AN63NQ64A, 
which displays significantly enhanced phosphorylation (ap-
proximately 48% higher). A time course of the reaction (Fig. 3B) 
demonstrates that the increase in phosphorylation observed for 
T62NV63NQ64A is due to an increase in the rate of phospho-
rylation compared to the wild-type protein. 
The Loop I mutants were also assayed for their ability to 
activate Gt (Fig. 3C). Initial rates of activation comparing the 
mutants with wild-type rhodopsin expressed in HEK-293 cells 
suggest that T62AN63NQ64A is normal in its ability to cata-
lyze the binding of GTP-yS to Gt, despite its enhanced rate of 
phosphorylation described above. L72NN73A also showed a 
small (approximately 27%) decrease in Gt activation although 
it was phosphorylated normally by rhodopsin kinase. The other 
four mutants demonstrated no significant differences in either 
Gt activation or phosphorylation compared to the wild-type 
protein. 
Mutations in Loop II-Loop II has been implicated in the 
activation of Gt by peptide competition experiments as well as 
deletion and substitution mutagenesis (6, 8). The triple alanine 
mutants generated in Loop II are shown in Table I. Rl47N 
F148NG149A demonstrated significantly reduced levels of 
phosphorylation, approximately 43% lower than wild-type rho-
dopsin (Fig. 4A). S144A/N145AIF146A also demonstrated a 
small reduction (26%) in phosphorylation. In Fig. 48, a time 
course for R147AIF148NG149A indicates that the reduced 
phosphorylation is due to a decreased rate of phosphorylation 
by rhodopsin kinase. The Loop II mutants all displayed normal 
activation of Gt (Fig. 4C). These data suggest that sites in Loop 
II participate specifically in regulating the phosphorylation of 
rhodopsin by rhodopsin kinase. 
Mutations in Loop III-For many G protein-coupled recep-
tors, including rhodopsin, the third cytoplasmic loop has been 
shown to be important for both G protein activation and G 
protein selectivity (6, 8, 29-32). Peptide competition studies 
also suggested that rhodopsin's Loop III plays a role in regu-
lating the phosphorylation of rhodopsin by rhodopsin kinase 
and the binding of arrestin (14, 15, 18, 33). Mutations were 
generated in this loop by alanine-scanning mutagenesis with 
the exception of Ala233-Ala234-Ala235, which was mutated first 
to glycines (Table 1). Because the introduction of glycine is 
known to disrupt the secondary structure of a helices (34), 
asparagines were also substituted for these three alanines. All 
of the mutants appeared to be normally phosphorylated com-
pared to wild-type rhodopsin except for A233G/A234G/A235G 
(Fig. 5A), reduced by approximately 80%, and A233N/A234N/ 
A235N (Fig. 6A), reduced by approximately 78%. 
A233G/A234G/A235G also showed a dramatic loss in ability 
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FIG. 4. Phosphorylation and Gt activation of Loop II mutants. 
A, phosphorylation by rhodopsin kinase. Membranes from transfected 
HEK-293 cells were harvested and assayed for phosphorylation as 
described under "Experimental Procedures" and the legend to Fig. 3. 
The results are expressed as a fraction of the level of light-dependent 
phophorylation for wild-type rhodopsin normalized to a value of 1.0 and 
represent the averages of duplicates from at least two transfections. 
The error bars represent S.E. B, time course of phosphorylation of 
R147AIF148A/a149A compared to wild-type rhodopsin. Membranes 
were phosphorylated and quantified as described under "Experimental 
Procedures" and in the legend to Fig. 2. Phosphorylation was performed 
in the light (open symbols) and in the dark (closed symbols). D and •. 
wild-type rhodopsin; t::. and .6., R147AIF148A/a149A. C, activation of a •. 
Membranes expressing mutant rhodopsins were reconstituted with 11-




FIG. 5. Phosphorylation and G. activation of Loop III mutants. 
A, phosphorylation by rhodopsin kinase. Membranes from transfected 
HEK-293 cells were harvested and assayed for phosphorylation as 
described under "Experimental Procedures" and the legend to Fig. 3. 
The results are expressed as a fraction of the level of light-dependent 
phophorylation for wild-type rhodopsin normalized to a value of 1.0 and 
represent the averages of duplicates from at least two transfections. 
The error bars represent S.E. B, activation of a •. Membranes expressing 
mutant rhodopsins were reconstituted with 11-cis-retinal and assayed 
for the light-dependent binding of aTPyS to a. as described under 
"Experimental Procedures" and the legend to Fig. 3. Rates of activation 
calculated from the slopes of the lines are expressed as a fraction of 
wild-type rhodopsin normalized to a value of 1.0. The results represent 
the average of at least two independent transfections performed in 
duplicate. The error bars represent S.E. The average rate of aTPyS 
binding for wild-type rhodopsin was 0.1 molls·mol. 
to activate Gt (Fig. 5B). Therefore, this mutant displays a 
reduced coupling to its G protein as well as reduced phospho-
rylation. Interestingly, A233N/A234N/A235N seems to be less 
severely affected for Gt activation (Fig. 6B) than the glycine 
mutant of this sequence. Measurements of absorbance for 
A233G/A234G/A235G and A233N/A234N/A235N indicated 
that retinal binding is equivalent to wild-type (Fig. 7). There-
fore, the integrity of the transmembrane domains in these 
as described under "Experimental Procedures" and the legend to Fig. 3. 
Rates of activation calculated from the slopes of the lines are expressed 
as a fraction of wild-type rhodopsin normalized to a value of 1.0. The 
results represent the average of at least two independent transfections 
performed in duplicate. The error bars represent S.E. The average rate 
ofaTP'YS binding for wild-type rhodopsin was 0.1 molls·mol. 
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FIG. 6. Phosphorylation and G, activation of the Loop III mu-
tants A233N/A234N/A235N and A233G/A234G/A235G. A, phospho-
rylation by rhodopsin kinase. Membranes from transfected HEK-293 
cells were harvested and assayed for phosphorylation as described 
under "Experimental Procedures" and the legend to Fig. 3. The results 
are expressed as a fraction of the level of light-dependent phophoryla-
tion for wild-type rhodopsin normalized to a value of 1.0 and represent 
the averages of duplicates from at least two transfections. The error 
bars represent S.E. B, activation of G,. Membranes expressing mutant 
rhodopsins were reconstituted with 11-cis-retinal and assayed for the 
light-dependent binding of GTPyS to G, as described under "Experi-
mental Procedures" and the legend to Fig. 3. Rates of activation calcu-
lated from the slopes of the lines are expressed as a fraction of wild-type 
rhodopsin normalized to a value of 1.0. a, the results represent the 
average of two independent transfections performed in duplicate. Error 
bars represent S.E. b, error bars represent the range of duplicates from 
a single transfection. The average rate of GTPyS binding for wild-type 
rhodopsin was 0.05 mol/s·mol. 
mutants is preserved. 
The other Loop III mutants were also assayed for their 
ability to catalyze GTP-yS binding to Gt (Fig. 5B). Two of these 
mutants, T242A!l'243A and V250A!l'251AIR252A, demon-
strated 57% and 69% reduced ability to activate Gt, respec-
tively, despite normal levels of phosphorylation. These data 
suggest that multiple domains within Loop III are important 
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FIG. 7. Subtraction spectra of the Loop III mutants A233G/ 
A234G/A235G and A233N/A234N/A235N. Membranes were reconsti-
tuted with 11-cis-retinal and assayed for retinal binding in the dark and 
in the light as described under "Experimental Procedures." The spectra 
generated in the light were subtracted from the spectra generated in 
the dark to define the absorption peak of membranes from nontrans-
fected, wild-type, and mutant-transfected cells. 
DISCUSSION 
This report describes the use of alanine-scanning mutagen-
esis to define the participation of the cytoplasmic loops in the 
interaction of rhodopsin with rhodopsin kinase and with its G 
protein, Gt. Previously, this technique has been used to uncover 
the functions of specific domains for a variety of proteins, 
including the sites of interaction between human growth hor-
mone and its receptor (35), the effector binding region of G. 
(36), and muscarinic acetylcholine receptor sequence required 
for G protein activation (37). Although the role of amino acids 
similar to alanines may not be successfully evaluated by this 
technique, it has the advantage of being less disruptive than 
other methods of analysis. Palczewski et al. (18) demonstrated 
that a proteolytic fragment of rhodopsin missing the C-termi-
nal phosphorylation sites is required for maximal phosphoryl-
ation of a synthetic peptide substrate by rhodopsin kinase. 
Therefore, cytoplasmic domains distinct from the phosphoryl-
ation sites participate in the activation of the kinase. Rhodop-
sin kinase and Gt have been shown to compete for interaction 
with rhodopsin, suggesting the possibility of overlapping bind-
ing sites (38, 39). We have examined the phosphorylation of 
rhodopsin by rhodopsin kinase and the activation of Gt in 
parallel in order to identify regions of the cytoplasmic surface 
that participate specifically in the activation of these two 
proteins. 
In Loops I and II we were able to define regions that affect 
phosphorylation when they are mutated to alanines. We de-
tected a significant increase in phosphorylation in the Loop I 
mutant T62AIV63A/Q64A, although Gt activation was similar 
to wild-type rhodopsin. Several potential mechanisms may ac-
count for this observation, including a release of steric restraint 
or an increase in affinity for the kinase. In contrast, R147A/ 
F148A/G149A in Loop II showed reduced ability to be phospho-
rylated by rhodopsin kinase but normal activation ofGt. These 
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data suggest for the first time that domains that participate in 
the activation of rhodopsin kinase reside in these two loops. 
None of the mutations in Loop II described in this study ap-
peared to significantly affect Gt activation. Mutation of the 
highly conserved Arg135 (found at the border between the third 
transmembrane domain and Loop II of most G protein-coupled 
receptors) to uncharged amino acids abolishes the binding and 
activation of Gt (8-10). Therefore this amino acid, which was 
not included in our present studies, is critical for interaction 
with Gt. It would be interesting to determine the effects of 
mutations in Arg135 on phosphorylation by rhodopsin kinase in 
order to fully understand the role of this important amino acid. 
In Loop III we have detected a significant loss of both phos-
phorylation and Gt activation by mutation of Ala233-Ala234-
Ala235 to either glycines or asparagines. Interestingly, A233N/ 
A234N/A235N was less severely affected for Gt activation than 
the glycine mutant of this sequence. These observations sug-
gest that the conformational requirements may be moderately 
different for phosphorylation and G protein activation, as dem-
onstrated by Robinson et al. (40). It is not clear from our data 
whether these mutations have affected just the Ala233-Ala234-
Ala235 region or whether they have affected the secondary 
structure of the entire loop. Loop III is predicted by Fourier 
transform infrared spectroscopy to be an a helix (41). Computer 
analysis, based on Chou-Fasman algorithms (42), predicts that 
either glycines or asparagines substituted for the alanines will 
introduce turns in the Loop III sequence (data not shown). 
Previously, substitution of glycines, which are known to dis-
rupt a helices, at Thr242-Thr243 (located in the center of Loop 
III) resulted in a 90% loss in GTPase activity compared to a 
66% loss when these amino acids were substituted with valines 
(9). In addition, proteolytic cleavage of Loop III between Glu239 
and Ser240 destroys both the ability of the photoreceptor to 
activate rhodopsin kinase (18) and disrupts activation of Gt 
(43). These data, taken together with the present report, 
strongly suggest that the secondary structure of a large seg-
ment of this loop is critical for the ability of rhodopsin to couple 
to Gt as well as to promote phosphorylation of the C terminus 
by rhodopsin kinase. Loop III may be important for the confor-
mational changes that must occur in response to light to con-
vert rhodopsin to an active protein. Nevertheless, we cannot 
rule out through our present studies that Ala233-Aia234-Ala235 
alone may be the required sequence for these light-dependent 
conformational changes. Nor can we rule out the possibility 
that Gt and rhodopsin kinase have partially overlapping sites 
of interaction. Future studies will focus on additional muta-
tions using amino acids that are less disruptive to secondary 
structure to distinguish between these possibilities. 
Previously, the use ofpeptides as competitive inhibitors sug-
gested that the C-terminal region of Loop Ill is important for 
phosphorylation of the C terminus by rhodopsin kinase (14, 15). 
However, none of the mutants in that region affected phospho-
rylation in our assay. In contrast, we did observe reduced 
activation of Gt in the Loop III mutants T242A!I'243A and 
V250T251R252. T242A!I'243A was reduced by approximately 
55%, similar to the results by Franke et al. (9) where these 
amino acids were substituted with valines instead of alanines, 
as described above. Val250-Thr251-Ar~52, adjacent to the sixth 
transmembrane domain, has been identified for the first time 
by our studies as a critical site for Gt activation. Since both 
mutants showed normal phosphorylation, they appear to be 
important specifically for Gt activation. Franke et al. also dem-
onstrated that a mutant containing a deletion of the central 
region of Loop III that includes Thr242-Thr243 (amino acids 
#237-249) can bind Gt but is unable to catalyze guanine nucle-
otide exchange (8), suggesting that this region may be needed 
not for binding, but for the catalysis of guanine nucleotide 
exchange. Whether Val250-Thr251-Arg252 is involved in the 
binding or the activation of Gt remains to be determined in 
future experiments. Two amino acid mutations in Loop III 
(S240A and K348L) reported previously to be important in the 
activation of Gt (9) were not detected in our studies. The rea-
sons for these differences between the two laboratories are 
unclear. Perhaps they are due to differences in the assay con-
ditions, such as the use of membranes in our case compared to 
detergent-extracted proteins in the earlier report, and/or the 
use of different mutations at these sites. 
Little is known concerning the involvement of the cytoplas-
mic loops in the regulation of phosphorylation of other G pro-
tein-coupled receptors by GRKs. In contrast, there have been a 
number of studies implicating Loops II and III in the activation 
of various G proteins. For example, a hydrophobic amino acid 
located in Loop II, leucine in the M1 muscarinic acetylcholine 
receptor and phenylalanine in the 13-adrenergic receptor, is 
required for G protein-mediated signal transduction in these 
two receptors (37). Replacement of either amino acid with 
alanine led to a greater than 85% loss in coupling. In the 
present study, replacement of the equivalent amino acid in 
rhodopsin, Met143, had no effect on either Gt activation or 
phosphorylation by rhodopsin kinase. Therefore, the critical 
domains in rhodopsin may be different from those in some 
closely-related receptors. Both Loops II and III, as well as the 
"fourth cytoplasmic loop" (Loop IV, Fig. 1), have been impli-
cated in the selectivity of coupling of specific G proteins to 
receptors such as the metabotropic glutamate, muscarinic ac-
etylcholine, and J3-adrenergic receptors (31, 44). The participa-
tion of the rhodopsin cytoplasmic domains in the selectivity of 
coupling to G proteins remains to be determined. 
In summary, we have, for the first time, defined domains in 
Loops I and II of rhodopsin that specifically affect the activa-
tion of rhodopsin kinase and that are distinct from regions 
involved in Gt activation represented by mutations in Loop III. 
In addition, mutation of Ala233-Ala234-Ala235 in theN-terminal 
domain of Loop III disrupted both G protein activation and 
phosphorylation. Additional experiments will be needed to sep-
arate and define the specific amino acids that play a role in 
these two pathways and to understand their significance in 
signaling events mediated by rhodopsin. 
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